Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours

  1. Chen, X.
  2. Isambert, N.
  3. López-López, R.
  4. Giovannini, M.
  5. Pognan, N.
  6. Kapoor, S.
  7. Quinlan, M.
  8. You, B.
  9. Cui, X.
  10. Rahmanzadeh, G.
  11. Mau-Sorensen, M.
Journal:
British Journal of Clinical Pharmacology

ISSN: 1365-2125 0306-5251

Year of publication: 2023

Volume: 89

Issue: 3

Pages: 1046-1055

Type: Article

DOI: 10.1111/BCP.15544 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals